Sunny Pharmtech Inc. (TPEX:6676)

Market Cap	2.37B -26.4%
Revenue (ttm)	290.18M -40.2%
Net Income	-269.51M
EPS	-1.82
Shares Out	148.82M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	333,142
Average Volume	401,893
Open	15.75
Previous Close	15.95
Day's Range	15.35 - 17.50
52-Week Range	12.90 - 21.45
Beta	0.00
RSI	56.65
Earnings Date	Apr 17, 2026

About Sunny Pharmtech

Sunny Pharmtech Inc. engages in the research, development, and sale of new and generic drug in Taiwan, the United States, and internationally. Its products portfolio include lidocaine ointment that can be used as an anesthetic lubricant for intubation, which temporarily relieves pain associated with minor burns, sunburn, skin abrasions, and insect bites; cyanocobalamin injection for use in vitamin B12 deficiency and pernicious anemia caused by malabsorption; nitrofurantoin capsules for urinary tract infection; aminocaproic acid tablets for bloo...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 158
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6676

Financial Performance

In 2024, Sunny Pharmtech's revenue was 418.01 million, a decrease of -2.52% compared to the previous year's 428.83 million. Losses were -156.00 million, 146.4% more than in 2023.